Moreover, research has shown abnormal CTLA-4 functionality in T-cells from SLE patients, indicating that even when CTLA-4 expression is present, its regulatory effects may be compromised, leading to ineffective control of T-cell activation and proliferation [26]. The gene discussed is CTLA4; the disease is systemic lupus erythematosus.